Continuous Glucose Monitoring: The Current State of the Art

Report Code: HLC255A

Publish Date: May 2020

Publisher: BCC Publishing

Category: Health Maintenance

Customize This Report

Single User License: $2500

Member Price: FREE

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

This report is designed to investigate and discuss the latest developments in continuous glucose monitoring (CGM) for the management of diabetes. The study's goals include:

  • Presenting the current products in the U.S., EU and elsewhere.
  • Looking at the technology—both on the market and in development.
  • Tracing improvements that companies are engineering and where these improvements may lead within the market.
  • Examining how close the industry is to a device-based artificial pancreas (AP).
  • Exploring selected clinical trials, the conclusions drawn from the research, and how the clinical trials affect the further development of CGM.

Report Includes

  • An overview of the current state of the art for Continuous Glucose Monitoring (CGM) for diabetes
  • Encompassing details of CGM functionalities like how they work, who can use one, and when a CGM could help to better manage the disease
  • Insight into the key market dynamics (DROs), technology advancements, regulatory and reimbursement scenerio, and other market influencing factors
  • Evaluation of market potential for CGM system and corresponding market share analysis by type of end user
  • Review of selected clinical trials with relate to CGMs and related components such as sensors and pumps
  • Company profile descriptions of the leading market participants

Report Scope

The scope of this study includes what a CGM is, how it works and how a PWD wears the device. This study also includes advances in the technology—both those advances being seen in the market today and advances for which CE mark or FDA approval is pending. There is a section covering the pancreas and diabetes, including the continued growth in the number of diabetics and prediabetics in the U.S. and elsewhere. It covers selected clinical trials pertinent to the evolution and proliferation of CGMs. The scope of this report includes novel CGMs and components in development. These may or may not ever see market launch but should nonetheless be of interest to industry managers.

Also covered here are selected regulatory and reimbursement affairs. Regulatory guidelines need to keep abreast of the technological developments so that safe, effective devices may enter the market. Without sufficient, carefully crafted reimbursement or payer coverage, the devices will never get off the ground. Both favorable regulatory and reimbursement guidelines are needed if manufacturers are to continue to develop and commercialize the best equipment for managing diabetes.

Selected companies are profiled in this report. These include not only the market leaders—Dexcom, Medtronic, Abbott, Tandem and Insulet—but also smaller companies working on promising technology.

Not covered in the scope of this report is in-depth analysis of market values and growth rates. These are available in other BCC Research reports. Also not covered is the ultimate in artificial pancreas: the cell-based implant. While these are under development, for practical purposes implants seem to be some distance down the road.

Analyst Credentials

Valerie Kellogg, RRT, BA, MS/MBA is an experienced medical device and pharmaceutical professional with international market research experience. She has authored numerous reports on topics ranging from the treatment of obesity to ablation devices, from wound care to the treatment of chronic migraine. Her strong focus areas include oncology, treatment of chronic disease, the latest in surgical devices and analysis of potential acquisitions in the medical device markets.

Need a custom data table, graph, region, segment, companies or complete report? CUSTOMIZE NOW
Let us assist you! Our analysts are ready to tailor this report to your specific need. REACH OUT TO US TODAY

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Continuous Glucose Monitoring: The Current State of the Art76Free

Related Reports

Continuous Glucose Monitoring (CGM): Technologies and Global Markets

Published - Jan 2023 | Publisher - BCC Publishing | Code - HLC102D

The global CGM market should reach $20.7 billion by 2022 and $32.7 billion by 2027, with a compound annual growth rate (CAGR) of 9.5% during the forecast period of 2022-2027.

Home Health Monitoring Device Industry: Global Markets

Published - Jan 2021 | Publisher - Anand Gijare | Code - HLC268A

The global market for home health monitoring systems should grow from $12.3 billion in 2020 to reach $29.1 billion by 2025, at a compound annual growth rate (CAGR) of 18.8% during the period of 2020-2025.

Latest Development, Product Innovations and Treatments for Diabetes

Published - Mar 2020 | Publisher - Paul Taylor | Code - HLC249A

The global diabetes treatment market should grow from $80.9 billion in 2019 to $103.2 billion by 2024 at a compound annual growth rate (CAGR) of 5.0% for the period of 2019-2024.

Non-injectable Insulin

Published - Feb 2020 | Publisher - Anuj Pathak | Code - PHM224A

This comprehensive report provides an in-depth assessment of the global market for non-injectable insulin. The report's key objective is to analyze areas of opportunities, key developments and the impact of this technology on industry, specifically the pharmaceutical, biotechnology and healthcare sectors. The analysis also reviews the adoption of non-injectable insulin in developed and emerging markets.

Recent Reports

Medical Magnetic Resonance Imaging (MRI): Technologies and Global Markets

Published - May 2024 | Publisher - BCC Publishing | Code - HLC078F

The global market for medical magnetic resonance imaging (MRI) is expected to grow from $7.2 billion in 2023 and projected to reach $9.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.4% during the forecast period of 2023 to 2028.

Global Markets for Emerging Insulin Drug and Delivery Technologies: Focus on Syringes and Vials

Published - Mar 2024 | Publisher - Bejini Sandeep Kumar | Code - HLC156B

The global market for emerging insulin drug delivery devices is expected to grow from $55.8 billion in 2023 and projected to reach $88.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 9.8% from 2023 through 2028.

Global Cleanroom Technology Market

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC298A

The global market for cleanroom products is expected to grow from $7.5 billion in 2023 to $10.9 billion by the end of 2028, at a compound annual growth rate (CAGR) of 7.6% from 2023 through 2028.

Ophthalmic Devices, Diagnostics and Surgical Equipment: Global Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC083D

The global market for ophthalmic devices, diagnostics and surgical equipment is expected to grow from $32.5 billion in 2023 and forecast to reach $44.0 billion by the end of 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028.

Microelectromechanical Systems (MEMS) in Global Medical Markets

Published - Mar 2024 | Publisher - BCC Publishing | Code - HLC129B

The global market for microelectromechanical systems (MEMS) devices in medical applications is estimated to increase from $4.8 billion in 2023 to reach $7.2 billion by 2028, at a compound annual growth rate (CAGR) of 8.5% from 2023 through 2028.

Top Trending Reports

Cell and Gene Therapy Tools, and Reagents: Global Markets

Published - Nov 2022 | Publisher - BCC Publishing | Code - BIO208B

The global market for cell and gene therapy tools and reagents is estimated to grow from $8.3 billion in 2022 to $13.7 billion in 2027, with a compound annual growth rate (CAGR) of 10.6% for the period of 2022-2027.

ESG Trends in Chemical Industry

Published - Dec 2022 | Publisher - BCC Publishing | Code - ENV056A

This report focuses on the ESG trends in the chemical industry and evaluates the ESG implementation including current and future potential. The report utilizes various databases, including sustainability reports, annual reports, and other indicators used to develop the current market. The study provides detailed information on the main factors influencing ESG growth in the chemical industry. It enables the reader to understand the industry in general while also providing insight into the inter-relationship between ESG and the sustainable chemical industry. The report describes market growth, developing trends, industry leaders, and applications of ESG implementation in the  chemical industry.

Digital Pathology: Technologies and Global Markets

Published - Dec 2022 | Publisher - BCC Publishing | Code - HLC161D

The global digital pathology market is estimated to increase from $5.9 billion in 2022 to reach $10.7 billion by 2027, at a compound annual growth rate (CAGR) of 12.5% from 2022 through 2027.

Smartphone-Based Patient Monitoring: Global Market

Published - Nov 2022 | Publisher - BCC Publishing | Code - HLC285A

The global smartphone-based patient monitoring market should reach $21.5 billion by 2027 from $6.8 billion in 2022 at a compound annual growth rate (CAGR) of 25.9% for the forecast period of 2022 to 2027.

Seawater and Brackish Water Desalination

Published - Nov 2022 | Publisher - BCC Publishing | Code - MST052E

The global market for seawater and brackish water desalination is estimated to increase from $14.7 billion in 2022 to $21.7 billion by 2027, at a compound annual growth rate (CAGR) of 8.1% from 2022 through 2027.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Continuous Glucose Monitoring: The Current State of the Art
Customize Report